Search

Your search keyword '"Bloomfield, Marketa"' showing total 129 results

Search Constraints

Start Over You searched for: Author "Bloomfield, Marketa" Remove constraint Author: "Bloomfield, Marketa"
129 results on '"Bloomfield, Marketa"'

Search Results

2. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

5. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

6. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

7. Nationwide observational study of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the Czech Republic

16. Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases

17. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

19. Expanded population of lowdensity neutrophils in juvenile idiopathic arthritis.

20. Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

22. Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS)

23. Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children

24. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

25. EAACI statement on the pathogenesis, immunology, and immune-targeted management of the Multisystem Inflammatory Syndrome in Children (MIS-C) or Pediatric Inflammatory Multisystem Syndrome (PIMS).

29. B cells, BAFF and interferons in MIS-C

30. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

31. Pathogenesis, immunology, and immune‐targeted management of the multisystem inflammatory syndrome in children (MIS‐C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper.

32. Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study

33. TLR8 / TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins

34. Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain-of-Function (GOF) Mutations – 10 Children and Review of the Literature

37. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

38. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

39. SARS-CoV-2-related MIS-C:A key to the viral and genetic causes of Kawasaki disease?

41. The prevalence, clinical relevance and origin of autoantibodies in patients with Common variable immunodeficiency on regular immunoglobulin replacement therapy – the results from a prospective observational study

42. Mendelian Susceptibility to Mycobacterial Disease: The First Case of a Diagnosed Adult Patient in the Czech Republic

45. TLR8/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins.

46. Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils’ but Impaired Monocytes’ and Dendritic Cells’ Responsiveness

47. Complex Immunometabolic Profiling Reveals the Activation of Cellular Immunity and Biliary Lesions in Patients with Severe COVID-19

49. Complex Immuno-metabolic Profiling Reveals Activation of Cellular Immunity and Biliary Lesion in Patients with Severe COVID-19

50. Mutual alteration of NOD2-associated Blau syndrome and IFNγR1 deficiency

Catalog

Books, media, physical & digital resources